Company News

Share this article:

Sepracor moved creative duties for Lunesta from The Kaplan Thaler Group, a New York-based Publicis shop, to Lowe, an IPG shop, Adweek reported. Prior to The Kaplan Thaler Group, the creative account was handled by IPG's McCann HumanCare.

Bioniche Pharma, a manufacturer of specialty injectables, received a warning letter from DDMAC regarding web pages for Sotradecol (sodium tetradecyl sulfate injection) located on the Bioniche and AngioDynamics websites. The pages “fail to communicate any information about the risks associated with the product,” the letter stated. Bioniche was cited for the same violations in April of 2006. Sotradecol is indicated in the treatment of small, uncomplicated varicose veins.


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.